Our Team

Brent Jacobs

Executive Managing Director | C&W Life Science Advisory Group
858.558.5627 | brent.jacobs@cushwake.com | Lic. #791657
Visit Brent Jacobs on LinkedIn

Brent Jacobs has been Executive Director of C&W’s LSAG for more than 30 years and is cofounder of BIOCOM, where he co-chairs the facilities committee. Mr. Jacobs is also co-founder of Big Bear Bio, a consulting firm that links North American biotechnology companies with Asian Capital. He has brokered more than 10 million sq. ft. of laboratory space, including more than 1.5 million sq. ft. of leasing and acquisition for Idec Pharmaceuticals and Biogen Idec.

Clients represented include: Amylin Pharmaceuticals, Althea Technologies, Avanir, Cibus, Covax, Conforma, CombiChem, SGX, Idun, Takeda, Tanabe, Ligand, Eli Lilly, Gen-Probe, Hybritech, Genta, Gensia, Kirin Life Sciences, Quidel, CovX Pharmaceuticals and Genzyme.

Mr. Jacobs has also represented the following academic and research institutions: UCSD, UCLA, UCSB, Sanford-Burnham, Salk, Scripps, John Wayne Cancer Institute, La Jolla Institute of Molecular Medicine, Torrey Pines Institute, La Jolla Institute of Allergy and Immunology, L.G. Biomedical and the Venter Institute.

He is regularly a bio-industry speaker and SIOR on biotechnology facilities. Mr. Jacobs is on the Executive Board of Directors of the Sanford-Burnham Institute, one of the nation’s top biomedical research institutes, and he recently chaired the Oversight Committee for the Sanford-Burnham Institute’s 175,000 sq. ft. laboratory facility in Orlando, Florida. He is a board member of the American Technion Society and a past Trustee of the Ruben H. Fleet Science Center and The La Jolla Institute for Molecular Medicine. He chairs CONNECT’s Entrepreneur Hall of Fame and is Chairman of the San Diego Innovation Center.

Greg Bisconti

Executive Director | C&W Life Science Advisory Group
858.558.5663 | greg.bisconti@cushwake.com | Lic. #1167920
Visit Greg Bisconti on LinkedIn

With more than 25 years of commercial real estate experience, Greg Bisconti has specialized exclusively in representing life science clients for 15+ years, focusing on tenant representation for the complex needs of small start-ups, fast growth companies, and large pharma clients. He has been personally involved in over 12 million square feet of lease and/or sale transactions, valued at over $4B in consideration, including cGMP manufacturing assignments and other special purpose facilities.

Starting with C&W in 1994, Greg has enjoyed a 20+ year career with Cushman & Wakefield and is a leader of its National Life Sciences Advisory Group. His clients have included Dexcom, Biogen Idec, Takeda, Synthetic Genomics, Inception Sciences, UCSD, BASF, Genomatica, Pfizer, Eli Lilly, Alexandria Real Estate Equities, Illumina, and a variety of cutting edge start-ups, such as Quanticel, Metacrine, Organovo, Jecure, and Ideaya, to name a few.

Greg is an active supporter and advocate of the life sciences industry, regularly assisting start-ups connect with mentors and capital sources. He serves on the BIOCOM Capital Development Committee, and is personally an angel investor for life science and healthcare companies.

Ted Jacobs

Executive Managing Director | C&W Life Science Advisory Group
858.558.5675 | ted.jacobs@cushwake.com | Lic. #1855220
Visit Ted Jacobs on LinkedIn

Ted Jacobs specializes in life sciences tenant representation transactions ranging from startups to Big Pharma. Ted has represented companies with the range of uses from cGMP, CLIA, biology, chemistry, etc. He has years of exposure to the life sciences industry as one of the partners on the C&W Life Science Advisory Group which is the first life sciences team in the country to specialize exclusively in life sciences real estate representation. In Ted’s first year of brokerage he was named rookie of the year. Ted is a licensed Real Estate Broker, a member of CONNECT, the BIOCOM Facilities Committee, and is on the Board of Directors of BIOCOM and the San Diego Entrepreneurs Exchange (SDEE). Ted earned a degree in Entrepreneurship from the Kelley School of Business and in Management from the School of SPEA at Indiana University.

Clients represented include: Ajinomoto Bio Pharma Services/ Althea Technologies, Lilly, LabCorp, Nitto Denko, Biological Dynamics, Kalypsys, Samumed, AltheaDx, Mirati Therapeutics, Maravai Life Sciences, Genzyme and Pfizer.

Alex Tsurdinis

Senior Brokerage Coordinator | C&W Life Science Advisory Group
858.334.4048 | alex.tsurdinis@cushwake.com | CA Lic. #02056232
Visit Alex Tsurdinis on LinkedIn

Alex Tsurdinis brings more than 8 years of marketing and administrative support experience to C&W LSAG’s client service and overall process management. Prior to joining Cushman & Wakefield, she worked as Client Services Director/ Marketing Specialist at Location Matters, a boutique retail commercial brokerage firm specializing in restaurants.

Ms. Tsurdinis graduated from James Madison University with a degree in Writing, Rhetoric, and Technical Communication.